Skip to main content

Mirus Launches Award Program Offering Transfection Products


Mirus Bio this week announced that it has launched an awards program to provide certain of its products to research teams that aim to use the company's transfection products in scientific investigations.

The program will run through 2012 and provide eligible labs with $5,000, $3,000, or $2,000 worth of Mirus products, as well as technical support. Winners will be chosen based on the quality of the research submitted to the company, the research area, and the proposed novel use of Mirus products.

The company said that labs receiving the awards that publish or present scientific findings referencing Mirus will be eligible for additional awards for a second year.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.